2d
MyChesCo on MSNOptinose Reports 2024 Financial Results, Highlights Prescription Growth and First Operational IncomeOptinose (NASDAQ: OPTN) has announced its financial results for the year and quarter ending December 31, 2024, spotlighting ...
3don MSN
CFO Lisa Roger reported Q4 2024 revenue of $2.8 million, detailing the growth was driven by expanded bottle production capacity and increased sales volumes. Full-year revenue reached $10.7 million, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results